Ticker APLS – Apellis Pharma – sales, description, marketcap – Tickerday.com

APLS

Apellis Pharma

–

Index: NASDAQ; Sector: Healthcare; Industry: Biotechnology & Drugs;

Marketcap: 2.18B; Volume: 432.73K; AvgVol 3m: 639.98K; Beta: –;

Cost estimate:

P/E: –; EPS: -7.61; EPS growth quarter/prev quarter: -39.70%;

EPS growth this year: -108.90%; EPS growth past 5 years: ;

EPS ttm: -7.61;

P/S: ; P/B: 10.60; P/Cashflow: 03.05; P/FCF: ;

Sales: –; Sales growth quarter/prev quarter: ; Sales growth past 5 years: ;

Profitability:

Gross Margin: ; Profit Margin: ; Operating Margin: ;

ROA – return on assets: -77.90%; ROE – return on equity: -283.10%; LT Debt/Equity: 1.50; Total Debt/Equity: 0.00;

Dividend: –; Dividend Yield (%): –;

Insider Ownership: 2.40%; Insider Transactions:-0.93%;

Institutional Ownership: 82.60%; Institutional Transactions: 11.02%;

Data update: 07/10/2020.